Literature DB >> 7693901

Patterns of integrin common chain beta 1 and collagen IV immunoreactivity in hepatocellular carcinoma. Correlations with tumour growth rate, grade and size.

C Patriarca1, M Roncalli, M Gambacorta, M Cominotti, G Coggi, G Viale.   

Abstract

Thirty cases of hepatocellular carcinoma (HCC) were investigated immunocytochemically for expression of beta 1 integrin molecule and of collagen IV. Immunoreactivity was related to the tumour proliferation index, as detected by PCNA immunostaining, and to tumour size and grade. Membrane beta 1 integrin immunoreactivity was detected in the neoplastic cells of all cases, though two different staining patterns were clearly recognized. In 14 cases, beta 1 integrin immunoreactivity was confined to the cell-stroma interface, showing the same polarized pattern as the non-neoplastic cell counterpart. This staining pattern was associated significantly (P < 0.0001) with low PCNA labelling (i.e. less than 20 per cent of neoplastic cells showing nuclear immunostaining. Conversely, 16 cases showed non-polarized pericellular beta 1 integrin immunostaining. This staining pattern was significantly associated (P < 0.0001) with high PCNA labelling (more than 20 per cent of immunoreactive cells) and with tumour size greater than 4 cm in diameter (P < 0.0001). beta 1 Integrin, collagen IV, and PCNA immunoreactivities, however, did not correlate with the histological grade. The data emphasize that neoplastic progression of HCCs may be correlated with an aberrant expression of adhesion molecules and with a disruption of the collagen IV complement of basal membranes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693901     DOI: 10.1002/path.1711710104

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  5 in total

1.  Integrin gene expression profiles of human hepatocellular carcinoma.

Authors:  Lian-Xin Liu; Hong-Chi Jiang; Zhi-Hua Liu; Jing Zhou; Wei-Hui Zhang; An-Long Zhu; Xiu-Qin Wang; Min Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

2.  Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells.

Authors:  Jörg Schrader; Timothy T Gordon-Walker; Rebecca L Aucott; Mariëlle van Deemter; Alexander Quaas; Shaun Walsh; Daniel Benten; Stuart J Forbes; Rebecca G Wells; John P Iredale
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

3.  Analysis of transcripts encoding novel members of the mammalian metalloprotease-like, disintegrin-like, cysteine-rich (MDC) protein family and their expression in reproductive and non-reproductive monkey tissues.

Authors:  A C Perry; R Jones; L Hall
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

4.  Extracellular matrix proteins, integrin receptors (VLA-beta 1, VLA-alpha 2 and VLA-alpha 5) and growth fraction in atypical macroregenerative nodules of the liver: an immunocytochemical case study.

Authors:  C Patriarca; M Roncalli; G Viale; R M Alfano; P Braidotti; F Guddo; G Coggi
Journal:  Histochemistry       Date:  1994-08

5.  VLA2 integrin expression in breast carcinomas evaluated by automated and quantitative immunohistochemistry.

Authors:  C Charpin; S Garcia; D Bergeret; L Andrac; N Horschowski; R Choux; M N Lavaut
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.